VC deal makes 16 times cost

3i and SEB Företagsinvest are selling Swedish vaccine distributor SBL Vaccines to Dutch biotechnology company Crucell for €39.4 million, generating an approximate 16 times return of the vendors’ investment.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this